Experience

Davis Polk advised the underwriters, in connection with a $2.2 billion dual-listed U.S. and Canadian initial public offering of  75,000,000 subordinate voting shares ($1.425 billion)…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $450 million aggregate principal amount of its 0.375% convertible senior notes due…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Bandwidth Inc. of an aggregate principal amount of $400 million of its 0.25% convertible senior…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Revance Therapeutics, Inc. of $287.5 million aggregate principal amount of its 1.75% convertible senior…

Davis Polk advised SMART Global Holdings, Inc. in connection with a Rule 144A offering of $250 million aggregate principal amount of its 2.25% convertible senior notes due 2026. Davis Polk…

Davis Polk advised the joint book-running managers and representatives of the initial purchasers on a Rule 144A offering by Integra LifeSciences Holdings Corporation of $575 million…

Davis Polk acted as special product counsel to the representative of the initial purchasers in connection with a Rule 144A offering by Live Nation Entertainment, Inc. of an aggregate…

Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with Bank of America Corporation’s $1.1 billion SEC-registered offering of…

Davis Polk advised the dealer managers in connection with a cash tender offer by Hamburg Commercial Bank AG (“HCOB”) to certain institutional investors in respect of the outstanding €500…

Davis Polk is advising TGLT S.A. in connection with a series of recapitalization transactions pursuant to an restructuring support agreement (the “RSA”) entered into between TGLT and an ad…